Table 2.
Cox’s regression analyses for overall survival.
| Text | 0–90 days |
91–365 days |
>365 days |
|||
|---|---|---|---|---|---|---|
| Baseline modela | Baseline model with CRPb and PAc quartiles | Baseline model | Baseline model with CRP and PA quartiles | Baseline model | Baseline model with CRP and PA quartiles | |
| International Prognostic Index | ||||||
| Low | Reference | Reference | Reference | Reference | Reference | Reference |
| Low/intermediate | 1.65 (0.37–7.36)d | 1.21 (0.27–5.45) | 3.09 (1.47–6.49) | 2.75 (1.30–5.81) | 1.61 (1.01–2.58) | 1.66 (1.03–2.68) |
| High/intermediate | 4.73 (1.37–16.3) | 2.30 (0.65–8.18) | 2.67 (1.28–5.57) | 1.96 (0.92–4.16) | 1.68 (1.07–2.65) | 1.50 (0.92–2.43) |
| High | 13.2 (4.06–43.2) | 6.05 (1.77–20.6) | 5.34 (2.64–10.8) | 3.64 (1.74–7.62) | 1.74 (1.03–2.95) | 1.52 (0.85–2.72) |
| CRP quartile (mg/L) | ||||||
| 1 (0–4.8) | – | Reference | – | Reference | – | Reference |
| 2 (5–24) | – | 0.77 (0.25–2.38) | – | 0.90 (0.47–1.73) | – | 0.98 (0.60–1.59) |
| 3 (25–79) | – | 0.74 (0.26–2.15) | – | 0.66 (0.34–1.29) | – | 0.89 (0.52–1.54) |
| 4 (80–433) | – | 0.97 (0.34–2.73) | – | 0.83 (0.43–1.61) | – | 0.78 (0.44–1.38) |
| PA quartile (g/L) | ||||||
| 1 (18–32) | – | Reference | – | Reference | – | Reference |
| 2 (33–37) | – | 0.30 (0.15–0.59) | – | 1.06 (0.65–1.74) | – | 0.54 (0.32–0.92) |
| 3 (38–41) | – | 0.20 (0.09–0.47) | – | 0.41 (0.22–0.77) | – | 0.62 (0.37–1.04) |
| 4 (42–52) | – | 0.04(0.01–0.32) | – | 0.21 (0.09–0.48) | – | 0.47 (0.27–0.84) |
aThe model that includes the International Prognostic Index only.
bC-reactive protein.
cPlasma albumin.
dHazard ratio (95% confidence interval).